Clinical Trial Update: Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports results for pembrolizumab combined with concurrent chemoradiotherapy or radiation therapy in small cell lung cancer, with the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Limited-stage Small Cell Lung Cancer
• Neuroendocrine Neoplasm

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2026-03-10